Aktuell Apr 11, 2024 Circunis wird von Seedling Foundation gefördert Circunis hat die Finanzierung für den Aufbau eines Online-Marktplatzes gesichert, über den überschüssige Lebensmittel und Nebenströme gehandelt w...
News Apr 11, 2024 Circunis obtains funding from the Seedling Foundation Circunis has secured financing to establish an online marketplace that can be used to trade surplus food and by-products. Following in the footst...
Success stories Apr 23, 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon Apr 23, 2024 10:15–12:10 Zürich Switzerland
Evento S-GE Fattori chiave di successo per fare affari in Giappone Apr 23, 2024 10:15–12:10 Zürich Switzerland
News Oct 11, 2023 SFITS, the Swiss Foundation for Innovation and Training in Surgery In the intricate, ever-evolving realm of medical science, the Swiss Foundation for Innovation and Training in Surgery (SFITS) is the platform whe...
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan Apr 23, 2024 10:15–12:10 Zürich Switzerland
Aktuell Apr 30, 2024 Johnson & Johnson eröffnet Innovation Hub in Allschwil Johnson & Johnson hat im Switzerland Innovation Park Basel Area den ersten J&J Innovation Hub auf dem europäischen Festland eröffnet. Es stellt e...
Innovation Mar 12, 2024 The Valley joins forces with S-GE to showcase Switzerland as a global hub for food and nutrition innovation Swiss Food & Nutrition Valley (SFNV), a network of more than 140 Swiss food innovators, has signed a strategic partnership with Switzerland G...
News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News May 22, 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News May 24, 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News May 21, 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...